Cargando…
Frequency of Bioprosthetic Valve Fracturing Utilization in an All-Comers Valve-in-Valve TAVR Cohort
Introduction: Valve-in-valve TAVR (ViV-TAVR) is an established treatment for failing surgical aortic valves in patient at high surgical risk. Elevated transprosthetic gradients are common after ViV-TAVR. Previously, bench tests showed feasibility of bioprosthetic valve fracturing (VF) using high-pre...
Autores principales: | Ruge, Hendrik, Erlebach, Magdalena, Lange, Ruediger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280286/ https://www.ncbi.nlm.nih.gov/pubmed/34277723 http://dx.doi.org/10.3389/fcvm.2021.653871 |
Ejemplares similares
-
Bioprosthetic Valve Fracturing: In vitro Testing of Edwards PERIMOUNT Model P 2900
por: Ruge, Hendrik, et al.
Publicado: (2022) -
Results of new-generation balloon vs. self-expandable transcatheter heart valves for bicuspid aortic valve stenosis
por: Deutsch, Oliver, et al.
Publicado: (2023) -
New adverse coronary events in valve-in-valve TAVR and native TAVR—A 2-year matched cohort
por: Koren, Ofir, et al.
Publicado: (2022) -
How to Avoid Coronary Occlusion During TAVR Valve-in-Valve Procedures
por: Valvo, Roberto, et al.
Publicado: (2019) -
Transcatheter Mitral Valve-in-Valve Implantation With a New Transcatheter Heart Valve for Bioprosthetic Degeneration
por: Lu, Yuntao, et al.
Publicado: (2022)